ACE2 and COVID-19: The novel coronavirus, SARS-CoV-2, produces its effects through its spike protein interaction with the Angiotensin-Converting Enzyme 2 (ACE2) receptors highly expressed in alveolar lung cells and the vascular endothelium in patients who have COVID-19 [6].